Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
News Alert: FDA highlights safety issue with leadless pacemakers
Thursday, November 18, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

News Alert

FDA highlights safety issue with leadless pacemakers, focusing on Medtronic’s Micra

All pacemakers are associated with a risk of cardiac perforation, the agency said, but perforation-related complications appear to be more severe with leadless pacing systems.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

FDA highlights safety issue with leadless pacemakers, focusing on Medtronic’s Micra

Share on Twitter Share on Facebook Share on Linkedin
All pacemakers are associated with a risk of cardiac perforation, the agency said, but perforation-related complications appear to be more severe with leadless pacing systems.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

New heart failure data show progress | Comparing 2 FDA-approved stroke drugs | Doctor accused of sexually assaulting colleagues
FDA clears new CCTA software for plaque evaluations | Family files lawsuit after heart transplant ends in tragedy
TAVR bests SAVR in terms of valve performance | Cardiology groups urge Congress to ‘take a stand’ | Updated SMART data
SCAI works to improve cath lab protection | Early AVR for asymptomatic severe AS boosts outcomes | New ASE guidelines
Week in Review: PFA catheters recalled | Devices pulled from market | FDA approves stroke drug | New ACS guidelines
The world’s first robotic transcatheter mitral valve replacements | Tiny pacemakers for infants | Building a CCTA program
FDA approves new stroke drug | First-in-human data on TAVR catheter from Boston Scientific | Surgical valve updates approved

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …90
    • Page 91
    • Page 92
    • Page 93
    • Current page 94
    • Page 95
    • Page 96
    • Page 97
    • Page 98 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme